Various embodiments of the invention provide human nucleic acid-associated
proteins (NAAP) and polynucleotides which identify and encode NAAP.
Embodiments of the invention also provide expression vectors, host cells,
antibodies, agonists, and antagonists. Other embodiments provide methods
for diagnosing, treating, or preventing disorders associated with
aberrant expression of NAAP.
